DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Prosthetic Heart Valve Market: Global Industry Analysis & Opportunity Assessment, 2016-2026" report to their offering.
The global prosthetic heart valve market revenue is projected to register a CAGR of 12.0% during the forecast period (2016-2026) and reach a market valuation of US$ 19.60 Bn by the end of 2026.
Mechanical heart valve is an artificial heart valve implanted in patients suffering from indicated diseases such as aortic stenosis or mitral regurgitation. Tissue heart valves are the biological valves harvested from cow heart sac (bovine) or porcine (pig) heart valves mounted on a stent or used without a stent to replace a dysfunctional heart valve.
Increasing occurrences of valvular heart disease (VHD) is one of the primary drivers impacting the global prosthetic heart valve market. Other factors fuelling the demand for prosthetic heart valves include regulatory approval for heart valves, integration of technological advancements, and increasing number of heart valve implantation procedures. Prosthetic heart values are an effective alternative to cumbersome open heart surgery, and this is one of the main reasons for a global preference for prosthetic heart valves.
However, high costs associated with transcatheter heart valve products, procedure related risks and complications, and product recalls are some restraints likely to hamper the growth of the global prosthetic heart valve market over the forecast period.
By Product Type
- Mechanical Heart Valves
- Mechanical Aortic Valve
- Mechanical Mitral Valve
- Biological/Tissue Heart Valves
- Tissue Aortic Valve
- Tissue Mitral Valve
- Transcatheter Heart Valves
- Transcatheter Aortic Valve
- Transcatheter Mitral Valve
By End User
- Ambulatory Surgery Centres
Leading players operating in the global prosthetic heart valve market
- Edwards Lifesciences Corporation
- St. Jude Medical, Inc
- Medtronic plc
- Boston Scientific Corporation
- Abbott Laboratories
- LivaNova PLC
- CryoLife, Inc
- Braile Biomedica
- Colibri Heart Valve LLC
- JenaValve Technology, Inc.
For more information about this report visit http://www.researchandmarkets.com/research/g9xmkt/prosthetic_heart